Back to Atlas
APotentially durableStandard research/education caution
CMP-0075
Discontinued/controlled in many markets
Methenolone acetate / Primobolan
Ergogenic / AAS
Mild lean-tissue preservation/anabolic effect
Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.
Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.
Mechanism & Use
- Compound type
- DHT-derived AAS
- Primary mechanism
- AR agonist; commonly cited A:A ~88:44-57
- Primary market use
- Muscle wasting/anabolic therapy history
Pharmacology
- Molecular weight (Da)
- 344.49
- Oral bioavailability
- Oral; clinically active acetate
- Half-life
- ~4-6 h (oral acetate approx.)
- Route tags
- Oral
- Evidence level
- Historical/clinical
- Clinical status
- Discontinued/controlled in many markets
- Value-for-money score
- 6 / 10
Reported protocol signal
No popular protocol verified yet; keep as reference compound until protocol signal is added.
For orientation only. See disclaimer — always consult a licensed clinician before use.
Notes
Ratio values are classic assay values; acetate is commonly the oral form.